Other studies have investigated the role of anoctamin-1 (ANO1) positive circulating tumor cells as potential biomarker in GIST reporting a sensitivity of 64.2% and a specificity of 88.1% [29, 30]. Here, ANO1 is linked to gastrointestinal stromal tumor.